Benjamin Hubbard, DO
Family Medicine · Spokane, WANPI 1154588978
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. Neuronetics, Inc. accounts for 64.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $1,887 and has fallen 76.2% since, to $448 in 2025. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $55.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$2K
- AbbVie$178
- Novo Nordisk$107
- Teva Pharmaceuticals USA, Inc.$105
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$94
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$85
- plus $368 from 13 others
What the payments were for
- Travel & lodging$1,09441%
- Food & beverage$1,54358%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 4 | $1,723 |
| AbbVie | 9 | $178 |
| Novo Nordisk | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $85 |
| Lilly USA, LLC | 1 | $73 |
| Amgen | 1 | $51 |
| Corcept Therapeutics | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Pfizer | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,660 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 13 | $20,043 |
| OxycontinOxycodone Hcl | 20 | $18,845 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,476 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $998 |
| Testosterone Cypionate | 13 | $917 |
| Oxycodone Hcl | 50 | $795 |
| Lidocaine | 22 | $779 |
| Pregabalin | 12 | $541 |
| Gabapentin | 20 | $426 |
| Estradiol | 21 | $394 |
| Methocarbamol | 12 | $356 |
| ProgesteroneProgesterone, Micronized | 11 | $305 |
| Omeprazole | 24 | $283 |
| Celecoxib | 13 | $258 |
| Fluoxetine Hcl | 29 | $240 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Spokane
- Stephenie MatosichSpokane$29K
- Duncan LahtinenSpokane$25K
- Gretchen LasalleSpokane$19K
- Jeffery TrailSpokane$12K
- Mark LahtinenSpokane$10K
- Philip HenrySpokane$9K
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.